
    
      This study is a double-masked, sham-controlled, parallel design prospective, multi-site study
      on the use of photobiomodulation (PBM) as a treatment for visual impairment in subjects with
      dry AMD. Subjects will receive repeated sham or PBM treatments at several time-points
      throughout the 2-year study.
    
  